GTV Spatial Conformity Between Different Delineation Methods by 18FDG PET/CT and Pathology in Esophageal Cancer

W. Yu,X. L. Fu,Y. J. Zhang,J. Q. Xiang,G. L. Jiang
DOI: https://doi.org/10.1016/j.radonc.2009.07.003
2008-01-01
Abstract:Purpose To find optimal threshold of length and GTV delineation for esophageal cancer using (18)FDG PETMaterials and methods. Sixteen patients with esophageal carcinoma underwent surgery For each patient. six GIVs were defined GTV(Cr) was based oil CT data alone GTV(20%) GTV(40%) GTV(25) and GTV(40%) were generated by PET/CT, using SUVbgd + 20%(SUVmax(slice)- SUVbgd), SUVbgd + 40%(SUVmax(slice)-SUVbgd). 2 5 and 40%SUVmax(total) as thresholds. GTV(path) was derived from pathology. Lengths of GTVs wera recorded as L-CT. L-20z, L-40z. L-25, L-40zm and L-path. respectively. The former five GIVs/lengths were compared with GTV(path)/L-path by means of a conformity index CI/CI', which Is the square of intersection of two GTVs/lengths divided by their product.Results. Mean L-CT, L-20%, L-40%. L-25. L-40%M and L-path were 6 30 +/- 2 69. 5 55 +/- 2 48.6 80 +/- 2 92, 6 65 +/- 2 66. 4 88 +/- 1 99 and 5 90 +/- 2 38 cm Mean Cl-CT&path. Cl-20%Apath. Cl-40%x path, Cl-25path and Cl-40%MA path were 0 68 +/- 0 16, 0 84 +/- 0.17. 0.76 +/- 0 14. 0 78 +/- 0.15 and 0 80 +/- 0.11. 020%s, and Cl-40%path was significantly superior to Cl-Cl&path (P<005) Mean GTV(CT). GTV(20%). GTV(40%). GTV(25). GTV(40%M) and GTV(path) were 29 16 +/- 18.56. 18.75 +/- 12.37. 12 52 +/- 8 08. 22 69 +/- 14 84, 9 18 +/- 5 96 anti 28.16 +/- 17 02 Increased significantly from Cl-40%path(0 27 +/- 0.09) and Cl-40%M&path(0.28 +/- 0.08) < Cl-20%path(0 52 +/- 0 16) and Cl-25path(0.52 +/- 0.20) < Cl-CT&path(0 77 +/- 0.17)Conclusions: The SUVbgd+20%(SUVmax,((slice))-SUVbgd) method optimally estimated gross tumor length, but only reached art unsatisfactory CI for GTV Due to possible motion factor enveloped in PET Images and lack of histopathologic transverse reference, the Information from both PET and CT should be referred to complementanly when delineating GTV. (C) 2009 Elsevrer Ireland Ltd All rights reserved Radiotherapy and Oncology 93 (2009) 441-446
What problem does this paper attempt to address?